Ipflufenoquin (Standard)

(R) -Omeprazole (sodium) (Standard) is the analytical standard of (R) -Omeprazole (sodium) . This product is intended for research and analytical applications. (R) -Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R) -Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R) -Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R) -Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19[1].